Noninvasive assessment of characteristics of novel anti-HER2
Por um escritor misterioso
Descrição
Noninvasive assessment of characteristics of novel anti-HER2 antibodies by molecular imaging in a human gastric cancer xenograft-bearing mouse model
Combination Therapies for Advanced Biliary Tract Cancer
Changes in ERa expression in response to HER2-directed therapy in the
Frontiers Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
Cancers, Free Full-Text
A) Distribution of the log‐transformed serum anti‐HER2 autoantibody
Molecules, Free Full-Text
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer - eBioMedicine
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial - The Lancet Oncology
Full article: Development of High-Loading Trastuzumab PLGA Nanoparticles: A Powerful Tool Against HER2 Positive Breast Cancer Cells
Cancers, Free Full-Text
Evaluation of an Anti-HER2 Nanobody Labeled with 225Ac for Targeted α-Particle Therapy of Cancer
de
por adulto (o preço varia de acordo com o tamanho do grupo)
